Edition:
United Kingdom

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

15,866.00ZAc
17 Oct 2018
Change (% chg)

-1,054.00 (-6.23%)
Prev Close
16,920.00
Open
16,902.00
Day's High
17,163.00
Day's Low
15,772.00
Volume
2,436,129
Avg. Vol
1,653,700
52-wk High
32,750.00
52-wk Low
15,079.00

Select another date:

Fri, Sep 21 2018

Aspen Pharma suffers week of woe as valuation tumbles by $3 bln

* Investors spooked by debt levels and sale of baby milk business

Drugmaker Aspen sells baby milk business to dairy giant Lactalis

JOHANNESBURG Aspen Pharmacare has agreed to sell its infant formula business to Lactalis for 12.9 billion rand (660.64 million pounds) to focus on core activities while the French buyer looks to revive its baby milk expansion after a health scandal.

South Africa's Aspen sells infant formula business to Lactalis for $865 million

JOHANNESBURG African drugmaker Aspen Pharmacare has agreed to sell its infant formula business to French dairy group Lactalis for 12.9 billion rand ($865 million), looking to capitalise on the sector's recent flurry of dealmaking to reduce its debt and focus on core operations.

Lactalis says Aspen deal to boost overseas business

PARIS Privately held French dairy group Lactalis said on Thursday its takeover of Aspen's global infant formula business would boost its presence in Latin America, Africa, Australia and Asia.

Lactalis says Aspen deal to boost overseas business

PARIS, Sept 13 Privately held French dairy group Lactalis said on Thursday its takeover of Aspen's global infant formula business would boost its presence in Latin America, Africa, Australia and Asia.

UPDATE 3-South Africa's Aspen in talks to sell infant formula unit

JOHANNESBURG, Sept 11 Aspen Pharmacare is in talks to sell its global infant formula business, it said on Tuesday, as the South African drug maker seeks to cash in on growing demand for baby milk.

South Africa's Aspen mulls sale of infant formula unit

JOHANNESBURG, Sept 11 South African drug maker Aspen Pharmacare said on Tuesday it was in discussions to sell its global infant formula business, but did not give any further details.

South African drugmaker Aspen secures 3.4 billion euro credit line

JOHANNESBURG, May 17 Aspen Pharmacare, Africa's biggest generic drugmaker, said on Thursday it had secured a 3.4 billion euro ($4 billion) credit facility for refinancing debt at three of its subsidiaries.

Aspen expands revenue-boosting therapeutic unit with new $80 million plant

PORT ELIZABETH, South Africa South African drug maker Aspen Pharmacare will produce up to 3.6 billion pills a year at its new manufacturing plant as it expands its therapeutic portfolio, Chief Executive Stephen Saad said on Monday at the official launch.

Aspen expands revenue-boosting therapeutic unit with new $80 million plant

PORT ELIZABETH, South Africa, May 7 South African drug maker Aspen Pharmacare will produce up to 3.6 billion pills a year at its new manufacturing plant as it expands its therapeutic portfolio, Chief Executive Stephen Saad said on Monday at the official launch.

Select another date: